Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-29

Clinical Trial Update: Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the combined effects of exercise and a GLP-1 receptor agonist on muscle microvascular perfusion and insulin action in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 receptor agonist (unspecified)

Snippet

Sponsor: University of Virginia | Conditions: Metabolic Syndrome | Phase 4 | Status: RECRUITING